查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132364

組織工程市場規模、佔有率和趨勢分析報告：按應用、地區和細分市場預測（2026-2033 年）

Tissue Engineering Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

組織工程市場概覽

全球組織工程市場預計到 2025 年將達到 221 億美元，從 2026 年的 253 億美元成長到 2033 年的 642 億美元，2026 年至 2033 年的複合年成長率為 14.2%。

預計到 2025 年，北美市場將佔據全球市場最大佔有率，達到 50.8%。對再生醫學日益成長的需求、慢性病盛行率的上升以及生物材料、幹細胞研究和 3D 生物列印技術的不斷進步正在推動市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：組織工程市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 組織工程市場分析工具

第4章 應用業務分析

  • 全球組織工程市場：按應用領域分類的趨勢分析
  • 全球組織工程市場：基於應用的規模和趨勢分析，2021-2033年
  • 臍帶血和細胞庫
  • 癌症
  • 胃腸病學/婦科
  • 牙科
  • 皮膚/表皮系統
  • 泌尿系統
  • 整形外科、肌肉骨骼系統、脊柱
  • 神經病學
  • 循環系統/血管
  • 其他

第5章：區域商業分析

  • 區域儀錶板
  • 組織工程市場：區域佔有率，2025 年和 2033 年
  • 北美洲
    • 2021-2033年北美組織工程市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲組織工程市場，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 亞太組織工程市場，2021-2033年
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲組織工程市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東和非洲組織工程市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭情勢

  • 公司和競爭對手的分類
  • 企業地位分析，2025 年
  • 策略規劃
  • 公司簡介列表
    • Zimmer Biomet Holdings, Inc.
    • AbbVie Inc.（Allergan）
    • BD
    • B. Braun
    • Integra LifeSciences Corporation
    • Organogenesis Holdings Inc.
    • Medtronic
    • ACell, Inc.
    • Athersys, Inc.
    • Tissue Regenix Group plc
    • Stryker Corporation
    • RTI Surgical, Inc.
    • ReproCell, Inc.
    • Baxter International, Inc.
Product Code: 978-1-68038-768-1

Tissue Engineering Market Summary

The global tissue engineering market size was valued at USD 22.1 billion in 2025 and is projected to grow from USD 25.3 billion in 2026 to USD 64.2 billion by 2033, growing at a CAGR of 14.2% from 2026 to 2033. The North America market held the largest share of 50.8% of the global market in 2025. The growing demand for regenerative medicine, the rising prevalence of chronic diseases, and ongoing advances in biomaterials, stem cell research, and 3D bioprinting are driving market growth.

Global Tissue Engineering Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global tissue engineering market based on application and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cord blood & Cell Banking
  • Cancer
  • GI, Gynecology
  • Dental
  • Skin & Integumentary
  • Urology
  • Orthopedics, Musculoskeletal, & Spine
  • Neurology
  • Cardiology & Vascular
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tissue Engineering Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in regenerative medicine
      • 3.2.1.2. Increasing prevalence of chronic diseases and traumatic injuries
      • 3.2.1.3. Growing investments in stem cell and cell & gene therapy research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of tissue-engineered products and regenerative therapies
      • 3.2.2.2. Ethical concerns related to stem cell research & tissue-engineered products
  • 3.3. Tissue Engineering Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Tissue Engineering Market Application Movement Analysis
  • 4.3. Global Tissue Engineering Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Billion)
  • 4.4. Cord blood & Cell banking
    • 4.4.1. Cord blood & cell banking market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.5. Cancer
    • 4.5.1. Cancer market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.6. GI, Gynecology
    • 4.6.1. GI, gynecology therapy market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.7. Dental
    • 4.7.1. Dental market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.8. Skin & Integumentary
    • 4.8.1. Skin & integumentary market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.9. Urology
    • 4.9.1. Urology market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.10. Orthopedics, Musculoskeletal, & Spine
    • 4.10.1. Orthopedics, musculoskeletal, & spine market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.11. Neurology
    • 4.11.1. Neurology market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.12. Cardiology & Vascular
    • 4.12.1. Cardiology & vascular market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.13. Others
    • 4.13.1. Others market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Dashboard
  • 5.2. Tissue Engineering Market: Share By Region, 2025 & 2033
  • 5.3. North America
    • 5.3.1. North America Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Mexico Tissue Engineering Market, 2021 - 2033 (USD Billion)
  • 5.4. Europe
    • 5.4.1. Europe Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.7. Sweden
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Sweden Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.8. Norway
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Norway Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.4.9. Denmark
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Denmark Tissue Engineering Market, 2021 - 2033 (USD Billion)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.5.2. China
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. China Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.5.3. Japan
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Japan Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.5.5. Australia
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Australia Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.5.6. Thailand
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Thailand Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.5.7. South Korea
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. South Korea Tissue Engineering Market, 2021 - 2033 (USD Billion)
  • 5.6. Latin America
    • 5.6.1. Latin America Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Brazil Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Argentina Tissue Engineering Market, 2021 - 2033 (USD Billion)
  • 5.7. MEA
    • 5.7.1. MEA Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. South Africa Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Saudi Arabia Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. UAE Tissue Engineering Market, 2021 - 2033 (USD Billion)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Kuwait Tissue Engineering Market, 2021 - 2033 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Company Position Analysis, 2025
  • 6.3. Strategy Mapping
  • 6.4. Company Profiles/Listing
    • 6.4.1. Zimmer Biomet Holdings, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. AbbVie Inc. (Allergan)
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. BD
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. B. Braun
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Integra LifeSciences Corporation
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Organogenesis Holdings Inc.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. ACell, Inc.
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Athersys, Inc.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Tissue Regenix Group plc
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Stryker Corporation
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. RTI Surgical, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. ReproCell, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Baxter International, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global tissue engineering market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 5 North America tissue engineering market, by country, 2021 - 2033 (USD Billion)
  • Table 6 North America tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 7 U.S. tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 8 Canada tissue engineering market, by application, (USD Billion) 2021 - 2033
  • Table 9 Mexico tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 10 Europe tissue engineering market, by country, 2021 - 2033 (USD Billion)
  • Table 11 Europe tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 12 Germany tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 13 U.K. tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 14 France tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 15 Italy tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 16 Spain tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 17 Sweden tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 18 Norway tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 19 Denmark tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 20 Asia Pacific tissue engineering market, by country, 2021 - 2033 (USD Billion)
  • Table 21 Asia Pacific tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 22 China tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 23 Japan tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 24 India tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 25 Thailand tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 26 South Korea tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 27 Australia tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 28 Latin America tissue engineering market, by country, 2021 - 2033 (USD Billion)
  • Table 29 Latin America tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 30 Brazil tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 31 Argentina tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 32 Middle East and Africa tissue engineering market, by country, 2021 - 2033 (USD Billion)
  • Table 33 Middle East and Africa tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 34 South Africa tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 35 Saudi Arabia tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 36 UAE tissue engineering market, by application, 2021 - 2033 (USD Billion)
  • Table 37 Kuwait tissue engineering market, by application, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Tissue engineering market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Tissue engineering market driver analysis
  • Fig. 12 Tissue engineering market restraint analysis
  • Fig. 13 Tissue engineering market: Porter's five forces analysis
  • Fig. 14 Tissue engineering market: PESTLE analysis
  • Fig. 15 Tissue engineering market: Application outlook and key takeaways
  • Fig. 16 Tissue engineering market: Application market share analysis
  • Fig. 17 Cord blood & Cell Banking market, 2021 - 2033 (USD Billion)
  • Fig. 18 Cancer market, 2021 - 2033 (USD Billion)
  • Fig. 19 GI, Gynecology market, 2021 - 2033 (USD Billion)
  • Fig. 20 Dental market, 2021 - 2033 (USD Billion)
  • Fig. 21 Skin & Integumentary market, 2021 - 2033 (USD Billion)
  • Fig. 22 Urology market, 2021 - 2033 (USD Billion)
  • Fig. 23 Orthopedics, Musculoskeletal, & Spine market, 2021 - 2033 (USD Billion)
  • Fig. 24 Neurology market, 2021 - 2033 (USD Billion)
  • Fig. 25 Cardiology & Vascular market, 2021 - 2033 (USD Billion)
  • Fig. 26 Others market, 2021 - 2033 (USD Billion)
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America tissue engineering market, by country, 2021 -2033 (USD Billion)
  • Fig. 29 U.S. tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 30 Canada tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 31 Mexico tissue engineering market, 2021 - 2033, (USD Billion)
  • Fig. 32 Europe tissue engineering market, by country, 2021 -2033 (USD Billion)
  • Fig. 33 UK tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 34 Germany tissue engineering market, 2021 - 2033, (USD Billion)
  • Fig. 35 France tissue engineering market, 2021 - 2033, (USD Billion)
  • Fig. 36 Italy tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 37 Spain tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 38 Denmark tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 39 Sweden tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 40 Norway tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 41 Asia-Pacific tissue engineering market, by country, 2021 -2033 (USD Billion)
  • Fig. 42 Japan tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 43 China tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 44 India tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 45 Australia tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 46 Thailand tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 47 South Korea tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 48 Latin America tissue engineering market, by country, 2021 -2033 (USD Billion)
  • Fig. 49 Brazil tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 50 Argentina tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 51 MEA tissue engineering market, by country, 2021 -2033 (USD Billion)
  • Fig. 52 South Africa tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 53 Saudi Arabia tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 54 UAE tissue engineering market, 2021 - 2033 (USD Billion)
  • Fig. 55 Kuwait tissue engineering market, 2021 - 2033 (USD Billion)